Melanoma trials in Brazil
1 of 9 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleNEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma
- Where
- São Paulo
- Age
- 18 years and over
- People
- 250
- Run by
- AC Camargo Cancer Center
See details and how to joinNCT07680699